DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
RYAZX
Price
$273.56
Change
-$0.24 (-0.09%)
Updated
Jul 31 closing price
Net Assets
20.75M
Interact to see
Advertisement

DFSVX vs RYAZX

DFSVX vs RYAZX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. RYAZX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and RYAZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. RYAZX (20.7M). DFSVX pays higher dividends than RYAZX: DFSVX (1.50) vs RYAZX (0.01). DFSVX was incepted earlier than RYAZX: DFSVX (33 years) vs RYAZX (22 years). RYAZX (1.60) is less costly to investors than DFSVX (0.31). RYAZX is a more actively managed with annual turnover of: 3783.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than RYAZX: DFSVX (0) vs RYAZX (2500). RYAZX annual gain was more profitable for investors over the last year : 38.88 vs. DFSVX (34.39). RYAZX return over 5 years is better than : 61.34 vs. DFSVX (50.66).
DFSVXRYAZXDFSVX / RYAZX
Total Expense Ratio0.311.5520%
Annual Report Gross Expense Ratio0.311.6019%
Fund Existence33 years22 years-
Gain YTD21.33624.35788%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B20.7M94,203%
Annual Yield % from dividends1.500.0111,753%
Returns for 1 year34.3938.8888%
Returns for 3 years50.3747.40106%
Returns for 5 years50.6661.3483%
Returns for 10 years107.71135.9579%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I